-
Sanofi will acquire the exclusive rights of Jixing Pharmaceutical to develop and commercialize Aficamten in Greater China
Securities Times E-Company News: Sanofi and Jixing Pharmaceutical announced today the signing of a formal agreement, which stipulates that Sanofi will acquire Jixing Pharmaceutical's exclusive rights ...